ClearTrial Industry Expert to Speak at CBI Forecasting and Budgeting Conference
|
Notes that Kristin Lucas of ClearTrial will present effective strategies for optimizing clinical trial planning, outsourcing and execution. She will review multiple new clinical development strategies, including the Functional Service Provider (FSP) outsourcing model, Electronic Data Capture (EDC), global studies, and preferred provider relationships, and highlight the areas in which clinical professionals should expect to find cost and time savings in a clinical budget and forecast.
Chicago, IL (PRWEB) January 24, 2008 — ClearTrial, a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing, announced today that Kristin Lucas, Director of Account Management for ClearTrial, will share innovative strategies for optimizing clinical trial planning at the Center for Business Intelligence (CBI) Clinical Trial Forecasting and Budgeting Conference. The conference, to be held February 7-8 at the Marriott Philadelphia West in West Conshohocken, Pennsylvania, provides the pharmaceutical and biotechnology industry with the latest tools, technologies and methods for improving clinical trial feasibility, budget accuracy and contract negotiation. During the conference, Ms. Lucas will present “Achieve Speed and Cost Savings when Using New Clinical Development Strategies” - a topic of ever-increasing importance given the rapid adoption of new clinical development strategies and technologies. She will review multiple new clinical development strategies, including the Functional Service Provider (FSP) outsourcing model, Electronic Data Capture (EDC), global studies, and preferred provider relationships, and highlight the areas in which clinical professionals should expect to find cost and time savings in a clinical budget and forecast. Just as importantly, Ms. Lucas will point to common pitfalls in these new strategies which often lead to hidden increases in clinical trial costs and time. The session will offer real-world examples of how organizations are dramatically compressing both the time and cost of clinical trial planning, forecasting and execution. Ms. Lucas brings more than 14 years of experience in the pharmaceutical and biotech industry to the conference. Before joining ClearTrial, she led the Financial division for the Clinical Business Management department at ICOS Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis. At ICOS, Ms. Lucas was responsible for establishing best practices in the outsourcing, management, drafting and negotiation of site and vendor agreements, as well as the development of a clinical budgeting/modeling application for lifecycle planning, budgeting and in-licensing opportunity assessment. In addition, she led the Sarbanes-Oxley audit preparedness project, resulting in ICOS achieving SOX compliance in 2006. Prior to ICOS, Ms. Lucas spent seven years with Genentech, where she was responsible for the negotiation, positioning, and pricing strategy for managed care contracts. She has extensive education and training in project management, negotiation, costing of clinical studies, advanced financial modeling, and marketing and business . About the Center for Business Intelligence About ClearTrial ClearTrial and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners. For more information, contact: Mike Lange # # # ClearTrial, LLC |
And some information of .
Posted by on 03-18-2008 at 12:03 am
Posted in Tadalafil
No Comments »
No comments yet.